TAE Life Sciences, Ohio State University partner to advance cancer drug development
TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC – James to develop boron-based drug compounds for cancer therapy.
TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC – James to develop boron-based drug compounds for cancer therapy.
What's Your Reaction?
